The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Theragenics sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Theragenics Corporation, United States Revenue

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Theragenics Corporation (Theragenics) manufactures surgical products and provides cancer treatments. The company primarily offers its products which include specialty needles, vascular access, vessel dilators, implantable mesh, gold fiducial markers, MRI markers, prostate implant seed cartridge, ocular seed carriers, valve adapters, specialty guidewires, wound closure and other surgical products. It also provides brachytherapy products which are used as treatment for the localized prostate cancer, ocular melanoma, and early-stage breast cancer. The company serves its products to various markets including, oncology, endoscopy, radiology, orthopedics, spine and sports medicine sectors. Theragenics is headquartered in Buford, Georgia and the US. Key subsidiaries of Theragenics include Galt Medical, NeedleTech Products and CP Medical.

The key metrics of Theragenics related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As Theragenics is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Theragenics.

For a detailed understanding of the performance of Theragenics, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.